Adial Pharmaceuticals, Inc.
ADIL
$0.33
$0.013.52%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 8.05% | -24.34% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.30% | -16.96% | |||
| Operating Income | 6.30% | 16.96% | |||
| Income Before Tax | 8.42% | 12.12% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 8.42% | 12.12% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 8.42% | 12.12% | |||
| EBIT | 6.30% | 16.96% | |||
| EBITDA | 6.31% | 16.96% | |||
| EPS Basic | 56.13% | 45.89% | |||
| Normalized Basic EPS | 56.08% | 45.92% | |||
| EPS Diluted | 56.13% | 45.89% | |||
| Normalized Diluted EPS | 56.08% | 45.92% | |||
| Average Basic Shares Outstanding | 108.72% | 62.43% | |||
| Average Diluted Shares Outstanding | 108.72% | 62.43% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||